Prostate Cancer Research Fund
Statistics show that one in 10 Caucasian males develop prostate cancer during their lifetime. Four in 100 prostate cancer patients die from this disease.
In Singapore, prostate cancer is occurring four times more frequently compared to 30 years ago. It is now the fifth most common cancer in our rapidly greying population, even afflicting men in their early 40s.
Prostate cancer develops in the prostate gland which is part of the male reproductive system. It can spread to other parts of the body. The cancer may cause pain, difficulty in urinating and other symptoms. In some cases, there are no obvious symptoms until the cancer reaches a late stage.
Research will help us gain a better understanding of prostate cancer in Asians relative to Caucasians and develop suitable diagnosis and treatment. To do this, we need S$1,800,000 to invest in cutting-edge medical research, using a molecular approach to study the genes and proteins related to prostate cancer present in Asian men. This programme, called the Asian Prostate Cancer Molecular Profiling Programme, will be conducted under the auspices of the SGH Prostate Institute's Asian Prostate Cancer Research Centre (APCRC).
Click here to download the form.